Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-14

Clinical Trial Update: QuantiFERON Change During Anti-tuberculosis Medication

View source ↗

Summary

Clinical trial update describing how QuantiFERON interferon-gamma release assay results change during anti-tuberculosis medication, based on the completed study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)

Snippet

Sponsor: Armed Forces Capital Hospital, Republic of Korea | Conditions: Tuberculosis, Interferon-gamma Release Assay | Status: COMPLETED